Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics
ROSELAND, N.J., March 10, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables across three pain management clinics in Colorado: Spine Correction Center of the Rockies; Colorado Clinic; and Colorado Accident and Injury. Adoption of the technology by these clinics follows a successful evaluation process by Dr. Brad Sisson, MD, a recognized pain management doctor. Dr. Sisson initially conducted five cases using the CompuFlo Epidural instrument, in which he reported 100% success. The evaluation included procedures within the thoracic region of the spine, following the recent FDA approval of the CompuFlo Epidural System for use in this indication. Dr. Sisson has practiced pain management in Colorado since 1998 and performed over 15,000 epidural procedures during his career.
Related news for (MLSS)
- Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
- MoBot’s Stock Market Highlights – 08/04/25 12:00 PM
- Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
- Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
- Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey